Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of Containment and Quarantine During COVID-19 Outbreack on Psychotic Symptoms in the General Population in France

NCT04356885 is registered in ClinicalTrials.gov with University Hospital, Montpellier as lead sponsor.

NCT NCT04356885
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04356885 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of Containment and Quarantine During COVID-19 Outbreack on Psychotic Symptoms in the General Population in France
Lead sponsor
University Hospital, Montpellier
Phase
Observational
Overall status
Completed
Start date
April 1, 2020
Completion date
August 1, 2020
Enrollment
600 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

mental disorder